Interactions of Klebsiella pneumoniae with the innate immune system vary in relation to clone and resistance phenotype
- PMID: 26349819
- PMCID: PMC4604363
- DOI: 10.1128/AAC.01405-15
Interactions of Klebsiella pneumoniae with the innate immune system vary in relation to clone and resistance phenotype
Abstract
Apart from inadequate antimicrobial treatment, specific virulence factors contribute to the high attributable mortality of infections caused by multidrug-resistant (MDR) Klebsiella pneumoniae. We explored the roles of MDR and clones as virulence determinants of K. pneumoniae and their interaction with innate immunity. Twenty isolates were studied and characterized by resistance phenotype and multilocus sequence type (MLST). Human peripheral blood mononuclear cells (PBMCs) were stimulated for the production of proinflammatory cytokines by live and heat-killed isolates and plasmid DNA; modulation by cellular pathway inhibitors was explored. Survival of 30 mice was recorded after intraperitoneal challenge with susceptible and K. pneumoniae carbapenemase (KPC)-producing isolates. Splenocytes of mice were stimulated for the production of pro- and anti-inflammatory cytokines. Isolates were divided into different patterns of production of tumor necrosis factor alpha (TNF-α) and interleukin-1β (IL-1β) poststimulation in relation to both the MLST clone and resistance phenotype. The sequence type 383 (ST383) clone producing Verona integron-encoded metallo-β-lactamase (VIM) stimulated high production of both TNF-α and IL-1β. Clone ST17 producing KPC elicited low TNF-α production; this was reversed by Toll-like receptor 9 (TLR9) antagonists, indicating an effect of plasmid DNA. This isolate was linked with early death of mice compared to high-TNF-α-producing isolates. We conclude that KPC-producing isolates seem to be highly virulent in a low-TNF-α-release environment, suggesting an immunoparalysis induction mechanism. KPC plasmids may directly contribute to the immune system stimulation.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.
Figures







Similar articles
-
Bloodstream infections caused by metallo-β-lactamase/Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes.Infect Control Hosp Epidemiol. 2010 Dec;31(12):1250-6. doi: 10.1086/657135. Epub 2010 Oct 25. Infect Control Hosp Epidemiol. 2010. PMID: 20973725
-
Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing plasmid-mediated KPC carbapenemase in Norway and Sweden.J Antimicrob Chemother. 2009 Apr;63(4):654-8. doi: 10.1093/jac/dkp018. Epub 2009 Feb 13. J Antimicrob Chemother. 2009. PMID: 19218573
-
ST11, the dominant clone of KPC-producing Klebsiella pneumoniae in China.J Antimicrob Chemother. 2011 Feb;66(2):307-12. doi: 10.1093/jac/dkq431. Epub 2010 Dec 3. J Antimicrob Chemother. 2011. PMID: 21131324
-
Identification and characterization of CTX-M-15 producing Klebsiella pneumoniae clone ST101 in a Hungarian university teaching hospital.Acta Microbiol Immunol Hung. 2015 Sep;62(3):233-45. doi: 10.1556/030.62.2015.3.2. Acta Microbiol Immunol Hung. 2015. PMID: 26551567 Review.
-
Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae: a review of epidemiological and clinical aspects.Expert Opin Biol Ther. 2012 Jun;12(6):663-71. doi: 10.1517/14712598.2012.681369. Epub 2012 Apr 16. Expert Opin Biol Ther. 2012. PMID: 22506862 Review.
Cited by
-
Genome-based analysis of Carbapenemase-producing Klebsiella pneumoniae isolates from German hospital patients, 2008-2014.Antimicrob Resist Infect Control. 2018 May 2;7:62. doi: 10.1186/s13756-018-0352-y. eCollection 2018. Antimicrob Resist Infect Control. 2018. PMID: 29744043 Free PMC article.
-
The Novel "RISC" Score as a Risk-prediction Model of Carbapenem-resistant Hospital-acquired Infections in Adult Sepsis Patients - A Prospective Observational Study.Indian J Crit Care Med. 2025 Apr;29(4):352-362. doi: 10.5005/jp-journals-10071-24953. Indian J Crit Care Med. 2025. PMID: 40322230 Free PMC article.
-
The Potential Role of the Intestinal Micromilieu and Individual Microbes in the Immunobiology of Chimeric Antigen Receptor T-Cell Therapy.Front Immunol. 2021 May 31;12:670286. doi: 10.3389/fimmu.2021.670286. eCollection 2021. Front Immunol. 2021. PMID: 34135898 Free PMC article. Review.
-
The Role of Adjunctive Therapies in Septic Shock by Gram Negative MDR/XDR Infections.Can J Infect Dis Med Microbiol. 2017;2017:2808203. doi: 10.1155/2017/2808203. Epub 2017 Jul 9. Can J Infect Dis Med Microbiol. 2017. PMID: 28775744 Free PMC article. Review.
-
Reduced Fitness Costs of mcr-1.2 Compared to Mutated pmrB in Isogenic Colistin-Resistant KPC-3-Producing Klebsiella pneumoniae.mSphere. 2019 Nov 6;4(6):e00551-19. doi: 10.1128/mSphere.00551-19. mSphere. 2019. PMID: 31694895 Free PMC article.
References
-
- Koupetori M, Retsas T, Antonakos N, Vlachogiannis G, Perdios I, Nathanail C, Makaritsis K, Papadopoulos A, Sinapidis D, Giamarellos-Bourboulis EJ, Pneumatikos I, Gogos C, Armaganidis A, Paramythiotou E, Hellenic Sepsis Study Group. 2014. Bloodstream infections and sepsis in Greece: over-time change of epidemiology and impact of de-escalation on final outcome. BMC Infect Dis 14:272. doi:10.1186/1471-2334-14-272. - DOI - PMC - PubMed
-
- Giamarellos-Bourboulis EJ, Papadimitriou E, Galanakis N, Antonopoulou A, Tsaganos T, Kanellakopoulou K, Giamarellou H. 2006. Multidrug resistance to antimicrobials as a predominant factor influencing patient survival. Int J Antimicrob Agents 27:476–481. doi:10.1016/j.ijantimicag.2005.12.013. - DOI - PubMed
-
- Daikos GL, Tsaousi S, Tzouvelekis LS, Anyfantis I, Psichogiou M, Argyropoulou A, Stefanou I, Sypsa V, Miriagou V, Nepka M, Georgiadou S, Markogiannakis A, Goukos D, Skoutelis A. 2014. Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems. Antimicrob Agents Chemother 58:2322–2328. doi:10.1128/AAC.02166-13. - DOI - PMC - PubMed
-
- Clinical and Laboratory Standards Institute. 2014. Performance standards for antimicrobial susceptibility testing; twenty fourth informational supplement. CLSI document M100-S124. Clinical and Laboratory Standards Institute, Wayne, PA.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous